National Lung Cancer Screening Program
EARLY DETECTION SAVES LIVES
National Lung Cancer Screening Begins 1 July 2025
LUNG CANCER IS THE FIFTH MOST FREQUENTLY DIAGNOSED MALIGNANCY IN AUSTRALIA AND REMAINS THE LEADING CAUSE OF CANCER-RELATED MORTALITY.
Evidence indicates that early detection significantly improves therapeutic efficacy and patient survival rates.
Commencing 1 July 2025, the National Lung Cancer Screening Program (NLCSP) will implement low-dose computed tomography (LDCT) to screen asymptomatic individuals at high risk of developing lung cancer. The program aims to facilitate earlier diagnosis, thereby reducing lung cancer mortality by an estimated 500 lives annually.
As of 1 July 2025, the National Lung Cancer Screening Program (NLCSP) in Australia offers biennial low-dose computed tomography (CT) scans to asymptomatic individuals at high risk of lung cancer. The program aims to detect lung cancer early, improving treatment outcomes and reducing mortality.
ELIGIBILITY CRITERIA
- AGE: Between 50 and 70 yrs old.
- SMOKING HISTORY: Currently smoking or have quit within the past 10 years.
- SMOKING INTENSITY: A history of at least 30 pack-years of cigarette smoking.</li<
- ASYMPTOMATIC: No signs or symptoms suggestive of lung cancer.
- INFORMED CONSENT: An informed choice to participate must be recorded.